Member Info for Cloudy390

Nightmare/sangi
If you don’t believe this then report them or hold your piece.
London, 28 November 2018 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, previously announced that it had submitted an Investigational New Drug (IND) application on 1 June 2018 to the U.S. Food and Drug Administration (FDA). Following approval of the IND application by the FDA, the Company announces that a first-in-human Phase 1 clinical trial in healthy volunteers has been initiated at the Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Well to be fair , that’s typical of Tils , Slow but sure.

Yes P2RE exactly!

UP!!!

To me sangi, it doesn’t matter how they get results or what it’s called, they can’t ignore good results, and anyway FDA can’t buy Tils.

Khee.

Whatever you call it .......

They are certainly letting it go ahead.!!!!

trial noun (TEST)


C1 [ C or U ]
a test, usually over a limited period of time, to discover how effective or suitable something or someone is:
Cambridge dictionary

Bye!

You read through all Tils news and don’t be lazy. Dyor.

So the fda won’t allow further patients in if all going well.
If you look back at some of our other trials we started with a few then more were added!!
Come on Sangi we all heard him say it and it’s happened before. dyor .

Not 1 patient Sangi , more will be fed in as no toxic and safe become apparent.
Don’t you listen!!!

PET scans going to be brilliant, actually see it working, we may even get a video.

Regulated news service, not a lie!!
Why let then try it on patients if the fda are unsure.

Proof of concept is all that’s needed!!

Because it is, as they well add more as they progress.

But ours is fully uman not umanised.

And umab is umanised mab

30 Oct 2020 demerger date.
Tils share price about £1.60p.
Happy days!